PATH | VRL
Menu

Find resources

Total results with these characteristics: 207

Disease: Meningococcus

Page 4 of 11
The Gavi Full Country Evaluations

The Gavi Full Country Evaluations (FCE) are prospective studies that aim to understand and quantify the barriers and drivers of immunization program improvement, with an emphasis on the contribution of Gavi, the Vaccine Alliance in four countries: …

Author: PATH

Global Alert and Response Disease Outbreak News: Meningococcal Disease

This web page provides regular updates on meningococcal disease outbreaks around the world as reported to the World Health Organization. It also serves as an archive, housing links to outbreak news alerts dating back to 1999.

Author: World Health Organization

Global and Regional Risk of Disabling Sequelae From Bacterial Meningitis: A Systematic Review and Meta-analysis

This article, published in The Lancet Infectious Diseases, provides an overview of a systematic review and meta-analysis of published papers from 1998 to 2008 to estimate the risks of major and minor sequelae caused by bacterial meningitis,  …

Author: Edmond K, Clark A, Korczak VS, et al.

Publication date: 2010

Global Burden of Disease

The Global Burden of Disease Study is the most comprehensive global observational epidemiological study to date. It describes mortality and morbidity from major diseases, injuries, and risk factors to health at the global, national, and regional …

Author: Global Burden of Disease Study Collaborators

Global Epidemiology of Invasive Meningococcal Disease

Neisseria meningitidis is one of the leading causes of bacterial meningitis globally and can also cause sepsis, pneumonia, and other manifestations. The worldwide epidemiology of invasive meningococcal disease (IMD) varies markedly by region and …

Author: Jafri RZ, Ali A, Messonnier NE, et al.

Publication date: 2013

Global Epidemiology of Meningococcal Disease

This article, published in the journal Vaccine, reviews meningococcal disease epidemiology and its variability across geographic area and time. The review summarizes the current status of meningococcal disease epidemiology by region, but notes that …

Author: Harrison LH, Trotter CL, Ramsay ME

Publication date: 2009

Global Epidemiology of Meningococcal Disease and Vaccine Efficacy

This article, published in the Pediatric Infectious Disease Journal, reviews outbreaks of meningococcal disease across the globe and the serotypes associated with these outbreaks. The author also discusses the different vaccines …

Author: Pollard AJ

Publication date: 2004

The Global Meningococcal Initiative: Recommendations for Reducing the Global Burden of Meningococcal Disease

The Global Meningococcal Initiative (GMI) is composed of an international group of scientists, clinicians, and public health officials that aim to promote the global prevention of invasive meningococcal disease through education and research. In …

Author: Harrison LH, Pelton SI, Wilder-Smith A, et al.

Publication date: 2011

A Global Vision for Meningitis by 2030 and an Action Plan to Get There

In May 2017, the Meningitis Research Foundation and the World Health Organization brought together over 50 global experts for a three-day meeting to shape a vision towards defeating meningitis and septicaemia by 2030. This report, building upon the …

Author: Meningitis Research Foundation

Publication date: 2017

Hope for Less Than 50 Cents a Dose: A Revolutionary Model for Developing Low-Cost Vaccines

This fact sheet describes the model employed by the Meningitis Vaccine Project to develop a safe, affordable, and long-lasting vaccine to combat Group A meningococcal epidemics in Africa, as well as the contributions of the key partners who made the …

Author: PATH

Publication date: 2011

Human Immunity to the Meningococcus: Development of Natural Immunity

This article, published in the Journal of Experimental Medicine, discusses a study in the United States that suggests that natural immunity to meningococcal disease is initiated, reinforced, and broadened by intermittent carriage of different …

Author: Goldschneider I, Gotschlich EC, Artenstein MS

Publication date: 1969

Human Immunity to the Meningococcus: Immunogenicity of Group A and Group C Meningococcal Polysaccharides in Human Volunteers

This article, published in the Journal of Experimental Medicine, provides a reinvestigation of the immunogenicity in human beings of the meningococcal group A and C antigens based on previous studies of the molecular weights of these polysaccharides …

Author: Gotschlich EC, Goldschneider I, Artenstein MS

Publication date: 1969

Human Immunity to the Meningococcus: Preparation and Immunochemical Properties of the Group A, Group B, and Group C Meningococcal Polysaccharides

This article, published in the Journal of Experimental Medicine, describes a new method for the isolation of the meningococcal group-specific polysaccharides that make it possible to produce highly purified group A and group C polysaccharides.

Author: Gotschlich EC, Liu TY, Artenstein MS

Publication date: 1969

Human Immunity to the Meningococcus: The Effect of Immunization With Meningococcal Group C Polysaccharide on the Carrier State

This article, published in the Journal of Experimental Medicine, discusses a small-scale field trial that was carried out in United States military recruits to test the effect of immunization with meningococcal C polysaccharide upon the …

Author: Gotschlich EC, Goldschneider I, Artenstein MS

Publication date: 1969

Human Immunity to the Meningococcus: The Role of Humoral Antibodies

This article, published in the Journal of Experimental Medicine, reviews an earlier study of the age-specific incidence of meningococcal meningitis in the United States that found that the proportion of individuals with serum bactericidal …

Author: Goldschneider I, Gotschlich EC, Artenstein MS

Publication date: 1969

A Hypothetical Explanatory Model for Meningococcal Meningitis in the African Meningitis Belt

Currently, no explanation exists for the epidemic pattern of meningitis in the African meningitis belt, in spite of recent progress in disease surveillance. Such a model would be conducive to mathematically mapping vaccine strategies or predicting …

Author: Mueller JE, Gessner BD

Publication date: 2010

Immune Response to Revaccination With Meningococcal A and C Polysaccharides in Gambian Children Following Repeated Immunization During Early Childhood

This article, published in the journal Vaccine, discusses a study of 42 Gambian children revaccinated at age five with meningococcal A/C polysaccharide vaccine (MPS) after receiving two doses of MPS in infancy and either MPS, meningococcal A/C …

Author: MacLennan J, Obaro S, Deeks J, et al.

Publication date: 1999

Immunization

This site offers information on vaccine and immunization programs at the American Academy of Pediatrics and includes video and text resources for parents. Resources include frequently asked questions for families, immunization information for …

Author: American Academy of Pediatrics

Immunization Matters

This quarterly e-newsletter provides updates from PATH’s Center for Vaccine Innovation and Access on late-stage and licensed vaccines included in its portfolio as well as its work on health economics and optimization, operations research, and …

Author: PATH

Immunization of Newborns with Bacterial Conjugate Vaccines

This article, published in Vaccine, discusses the use of bacterial conjugate vaccines in human newborns. Vaccines against Streptococcus pneumoniae, Haemophilus influenzae type B, and Neisseria meningiditis are covered. ABSTRACT ONLY: (Learn how …

Author: van den Biggelaar AH, Pomat WS

Publication date: 2013

Page 4 of 11